Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma
The mitochondrial genome (mtDNA) encodes essential machinery for oxidative phosphorylation and metabolic homeostasis. Tumor mtDNA is among the most somatically mutated regions of the cancer genome, but whether these mutations impact tumor biology is debated. We engineered truncating mutations of the...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/389180 |
| Acceso en línea: | http://hdl.handle.net/10261/389180 |
| Access Level: | acceso abierto |
| Palabra clave: | Cancer Cancer genetics Cancer immunotherapy Cancer metabolism Cancer microenvironment |
| id |
ES_736c49d8fd8eacd73d40394da2ff467a |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/389180 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanomaMahmood, MahnoorMinwei Liu, EricShergold, Amy L.Tolla, ElisabettaTait-Mulder, JacquelineHuerta-Uribe, AlejandroShokry, EngyYoung, Alex L.Lilla, SergioKim, MinsooPark, TriciaBoscenco, SoniaManchón, Javier L.Rodríguez-Antona, CristinaWalters, Rowan C.Springett, Roger J.Blaza, James N.Mitchell, LouiseBlyth, KarenZanivan, SaraSumpton, DavidRoberts, Edward W.Reznik, EdGammage, Payam A.CancerCancer geneticsCancer immunotherapyCancer metabolismCancer microenvironmentThe mitochondrial genome (mtDNA) encodes essential machinery for oxidative phosphorylation and metabolic homeostasis. Tumor mtDNA is among the most somatically mutated regions of the cancer genome, but whether these mutations impact tumor biology is debated. We engineered truncating mutations of the mtDNA-encoded complex I gene, Mt-Nd5, into several murine models of melanoma. These mutations promoted a Warburg-like metabolic shift that reshaped tumor microenvironments in both mice and humans, consistently eliciting an anti-tumor immune response characterized by loss of resident neutrophils. Tumors bearing mtDNA mutations were sensitized to checkpoint blockade in a neutrophil-dependent manner, with induction of redox imbalance being sufficient to induce this effect in mtDNA wild-type tumors. Patient lesions bearing >50% mtDNA mutation heteroplasmy demonstrated a response rate to checkpoint blockade that was improved by ~2.5-fold over mtDNA wild-type cancer. These data nominate mtDNA mutations as functional regulators of cancer metabolism and tumor biology, with potential for therapeutic exploitation and treatment stratification.This work was supported by CRUK Glasgow Centre (A18076), CRUK SI Advanced Technology Facilities (A17196). S.Z. was supported by Stand Up to Cancer campaign for CRUK SI Core Funding (A29800). P.A.G was supported by CRUK SI Core Funding (A31287 and A_BICR_1920_Gammage), European Research Council (ERC) Starting Grant (via UKRI: EP/X035581/1) and NIH (R37CA276200). E.R. was supported by Department of Defense Kidney Cancer Research Program (no. HT9425-23-1-0995), NIH R37 CA276200 and the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center. This work was supported by NIH/NCI Cancer Center Support Grant (P30 CA008748).Peer reviewedSpringer NatureCancer Research UKEuropean Research CouncilNational Institutes of Health (US)Alan and Sandra Gerry Metastasis and Tumor Ecosystems CenterNational Cancer Institute (US)Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202520252024info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/389180reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)InglésThe underlying dataset has been published as supplementary material of the article in the publisher platform at DOI https://doi.org/10.1038/s43018-023-00721-whttps://doi.org/10.1038/s43018-023-00721-wSíinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3891802026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| title |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| spellingShingle |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma Mahmood, Mahnoor Cancer Cancer genetics Cancer immunotherapy Cancer metabolism Cancer microenvironment |
| title_short |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| title_full |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| title_fullStr |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| title_full_unstemmed |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| title_sort |
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma |
| dc.creator.none.fl_str_mv |
Mahmood, Mahnoor Minwei Liu, Eric Shergold, Amy L. Tolla, Elisabetta Tait-Mulder, Jacqueline Huerta-Uribe, Alejandro Shokry, Engy Young, Alex L. Lilla, Sergio Kim, Minsoo Park, Tricia Boscenco, Sonia Manchón, Javier L. Rodríguez-Antona, Cristina Walters, Rowan C. Springett, Roger J. Blaza, James N. Mitchell, Louise Blyth, Karen Zanivan, Sara Sumpton, David Roberts, Edward W. Reznik, Ed Gammage, Payam A. |
| author |
Mahmood, Mahnoor |
| author_facet |
Mahmood, Mahnoor Minwei Liu, Eric Shergold, Amy L. Tolla, Elisabetta Tait-Mulder, Jacqueline Huerta-Uribe, Alejandro Shokry, Engy Young, Alex L. Lilla, Sergio Kim, Minsoo Park, Tricia Boscenco, Sonia Manchón, Javier L. Rodríguez-Antona, Cristina Walters, Rowan C. Springett, Roger J. Blaza, James N. Mitchell, Louise Blyth, Karen Zanivan, Sara Sumpton, David Roberts, Edward W. Reznik, Ed Gammage, Payam A. |
| author_role |
author |
| author2 |
Minwei Liu, Eric Shergold, Amy L. Tolla, Elisabetta Tait-Mulder, Jacqueline Huerta-Uribe, Alejandro Shokry, Engy Young, Alex L. Lilla, Sergio Kim, Minsoo Park, Tricia Boscenco, Sonia Manchón, Javier L. Rodríguez-Antona, Cristina Walters, Rowan C. Springett, Roger J. Blaza, James N. Mitchell, Louise Blyth, Karen Zanivan, Sara Sumpton, David Roberts, Edward W. Reznik, Ed Gammage, Payam A. |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Cancer Research UK European Research Council National Institutes of Health (US) Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center National Cancer Institute (US) Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Cancer Cancer genetics Cancer immunotherapy Cancer metabolism Cancer microenvironment |
| topic |
Cancer Cancer genetics Cancer immunotherapy Cancer metabolism Cancer microenvironment |
| description |
The mitochondrial genome (mtDNA) encodes essential machinery for oxidative phosphorylation and metabolic homeostasis. Tumor mtDNA is among the most somatically mutated regions of the cancer genome, but whether these mutations impact tumor biology is debated. We engineered truncating mutations of the mtDNA-encoded complex I gene, Mt-Nd5, into several murine models of melanoma. These mutations promoted a Warburg-like metabolic shift that reshaped tumor microenvironments in both mice and humans, consistently eliciting an anti-tumor immune response characterized by loss of resident neutrophils. Tumors bearing mtDNA mutations were sensitized to checkpoint blockade in a neutrophil-dependent manner, with induction of redox imbalance being sufficient to induce this effect in mtDNA wild-type tumors. Patient lesions bearing >50% mtDNA mutation heteroplasmy demonstrated a response rate to checkpoint blockade that was improved by ~2.5-fold over mtDNA wild-type cancer. These data nominate mtDNA mutations as functional regulators of cancer metabolism and tumor biology, with potential for therapeutic exploitation and treatment stratification. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/389180 |
| url |
http://hdl.handle.net/10261/389180 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI https://doi.org/10.1038/s43018-023-00721-w https://doi.org/10.1038/s43018-023-00721-w Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Springer Nature |
| publisher.none.fl_str_mv |
Springer Nature |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869410809059213312 |
| score |
15,812429 |